NEW YORK, Jan. 28 (GenomeWeb News) - Celera Genomics reported decreased revenues and net losses for its fiscal year 2004 second quarter today, accompanied by smaller R&D spending.
For the quarter ended Dec. 31, 2003, Celera Genomics, a unit of Applera, reported revenues of $19.2 million, compared to $22.9 million for the same period a year ago.
The company's net loss for the quarter totaled $13.6 million, or $0.19 per share, compared to $16.1 million, or $0.23 per share, in the prior year quarter.
Celera spent $25.2 million for R&D during the quarter, compared to $32.9 million the year before.
As of Dec. 31, 2003, Celera had cash and short term investments of about $770 milllion.